Winters Chad 4/A
4/A · WEST PHARMACEUTICAL SERVICES INC · Filed Dec 21, 2023
Insider Transaction Report
Form 4/AAmended
Winters Chad
VP, Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-04$173.22/sh+341$59,068→ 2,282.698 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-12-04−341→ 1,571 totalExercise: $173.22From: 2021-02-18Exp: 2030-02-18→ Stock Options (Right to Buy) (341 underlying) - Exercise/Conversion
Common Stock
2023-12-04$143.43/sh+456$65,404→ 1,941.698 total - Sale
Common Stock
2023-12-04$349.00/sh−1,013$353,541→ 1,269.698 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-12-04−456→ 0 totalExercise: $143.43From: 2020-10-29Exp: 2029-10-29→ Stock Options (Right to Buy) (456 underlying)
Footnotes (1)
- [F1]This is a revision to accurately reflect option exercises and sales that Chad Winters requested on December 1, 2023 that were completed on December 4, 2023 due to a record-keeping system outage.